Patents by Inventor Rhea Longley

Rhea Longley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System, method, apparatus and diagnostic test for
    Patent number: 11835520
    Abstract: A system, method, apparatus and diagnostic test for Plasmodium vivax, to determine a likelihood of a specific timing of infection by P. vivax in a subject, and hence identify individuals with a high probability of being infected with otherwise undetectable liver-stage hypnozoites. The system, method, apparatus and diagnostic test relate to the identification of hypnozoites (“dormant” liver-stages), or at least of the likelihood of the subject being so infected. Optionally and preferably, the specific timing relates to recent infections, for example within the last 9 months.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: December 5, 2023
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Ivo Mueller, Takafumi Tsuboi, Michael White, Rhea Longley
  • SYSTEM, METHOD, APPARATUS AND DIAGNOSTIC TEST FOR PLASMODIUM VIVAX
    Publication number: 20210132063
    Abstract: A system, method, apparatus and diagnostic test for Plasmodium vivax, to determine a likelihood of a specific timing of infection by P. vivax in a subject, and hence identify individuals with a high probability of being infected with otherwise undetectable liver-stage hypnozoites. The system, method, apparatus and diagnostic test relate to the identification of hypnozoites (“dormant” liver-stages), or at least of the likelihood of the subject being so infected. Optionally and preferably, the specific timing relates to recent infections, for example within the last 9 months.
    Type: Application
    Filed: December 21, 2017
    Publication date: May 6, 2021
    Applicant: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Ivo Mueller, Takafumi Tsuboi, Michael White, Rhea Longley
  • MALARIA VACCINATION
    Publication number: 20160250312
    Abstract: The invention relates to an antigenic composition or vaccine comprising a viral vector, the viral vector comprising nucleic acid encoding Plasmodium protein PfLSA1, or a part or variant of Plasmodium protein PfLSA1; PfLSAP2, or a part or variant of Plasmodium protein PfLSAP2; PfUIS3, or a part or variant of Plasmodium protein PfUIS3; PfI0580c, or a part or variant of Plasmodium protein PfI0580c; and PfSPECT-1, or a part or variant of Plasmodium protein PfSPECT-1.
    Type: Application
    Filed: October 13, 2014
    Publication date: September 1, 2016
    Inventors: Rhea Longley, Ahmed Salman, Alexandra Spencer, Adrian Hill, Chris Janse, Sahid Khan